12.06.01: Investing in the Pharmaceutical Industry Conference Issue
Five analysts, one money manager, six experts and top management from six sector firms examine the pharmaceutical sector in this special 78-page Investing in the Pharmaceutical Industry Conference issue from The Wall Street Transcript.

    Online subscribers to the Healthcare sector also get
    Outlook for Health Care & Pharmaceuticals Report & First Analysis Securities & NYSSA Specialty Chemicals & Life Sciences Conferences Issue

  1. Pharmaceutical Industry Outlook - In an in-depth (3,900 words) Analyst Interview, Jerry L. Treppel, Managing Director with Banc of America Securities LLC, examines the outlook for the sector and shares specific stock recommendations.
  2. Investing in Healthcare Funds - In an in-depth (4,100 words) Analyst Interview, David R. Blaustein, co-Portfolio Manager of Galleon Group, examines the outlook for the sector and shares specific stock recommendations.
  3. Pharmaceutical Industry Overview - In an in-depth (3,200 words) Analyst Interview, Jeffrey Kraws, Pharmaceutical Analyst and Senior Managing Director of the Healthcare Research Group at Gruntal & Co., LLC., examines the outlook for the sector and shares specific stock recommendations.
  4. Investing in the Pharmaceutical Industry - In an in-depth (3,200 words) Analyst Interview, Sergio Traversa, Portfolio Manager with the Merlin BioMed Group, examines the outlook for the sector and shares specific stock recommendations.
  5. David Saks, Founder and Chief Investment Officer of the Saks MedScience Fund, examines portfolio management strategies in this timely and deeply informative 5,700-word interview from The Wall Street Transcript.
  6. Managing Drug Costs - In an in-depth (1,600 words) Expert Interview, David Shook, Staff reporter for BusinessWeek Online, examines the outlook for the sector.
  7. Pharmaceutical Industry Outlook - In an in-depth (5,000 words) Expert Interview, Hugh Jones, Managing Director for Datamonitor, examines the outlook for the sector.
  8. Pharmaceutical Industry Outlook - In an in-depth (5,000 words) Expert Interview, Keith Ackerman, First Vice President of Instinet Corporation, examines the outlook for the sector.
  9. Human Services in Maine - In an in-depth (5,500 words) Expert Interview, Kevin W. Concannon, Commissioner of Health & Human Services for the State of Maine at Department of Human Services, examines the outlook for the sector.
  10. Pharmaceutical Executive - In an in-depth (4,200 words) Expert Interview, Wayne Koberstein, Editor-in-Chief of Pharmaceutical Executive magazine, examines the outlook for the sector.
  11. Outlook for Pharmaceuticals - In an in-depth (8,300 words) Expert Interview, William Trombetta, Professor of Pharmaceutical Marketing at the Erivan K. Haub School of Business, St. Joseph's University, examines the outlook for the sector.
  12. CEO interviews (average 2,500 words). Top management of six sector firms examine the outlook for their firm and the sector. Firms include:
    Bradley Pharmaceuticals, Hoffman-La Roche, NexMed, Pharmaceutical Resources, PRAECIS PHARMACEUTICALS, Ventiv Health
    13. ORDER THIS REPORT NOW! ONLY $175
    The report will be mailed first class. For fedex delivery, specify in the report details section and either include your fedex number or we will add $15 delivery charge. All sales are final.  Questions, call (212) 952-7433, or email us
    For immediate access online - click here to gain a password.
     
    Report details:  
    Your Name:  
    		 Company: 
    Address: 
    		 City: 
    State/Province:
    		 ZIP/Postal Code:
          		 Country:
    Phone:
    		 E-Mail:

    BILLING INFORMATION
    Credit Card
    		 Expiration Month/Year:
    Credit Card Number: 
     

     This Issue costs $175 - and is non-returnable.   

    The Wall Street Transcript does not endorse the views of any interviewee nor does it make stock recommendations.

     

Investors and Industry Execs.

The Wall Street Transcript has been used by investors and industry executives for 40 years as a unique tool for company and industry research.

TWST's roundtable panels and analyst interviews provide a sector perspective from Wall Street's best. 

Money manager interviews provide the view from the buy-side.

CEO interviews with hundreds of companies from the major sectors gives the company perspective right from the top.

Subscribe to a unique research tool for investors and industry executives. Call (212) 952 7433 or click here.

Sincerely,

Andrew Pickup
Publisher
HOME PRODUCTS SUBSCRIBE ABOUT ARCHIVE HOTLINE CONTACT EUROPE